So shareholders will have shares of
- Epgl with big value thanks to patents + JNJ agreement for buying Epgl IP technology ( at least for the autofocus technology, at least $5 billions of revenues by year, novartis Ceo talked about between $10 to 50 billions in the ten years to come (2015), I let you imagine the value of this sole autofocus technology).
- New company to manufacture at least the smart contact lens patented technology with Apple IOS and many more. They will need a big player to manufacture them, big partnerships with big players to come.
And the cherry on the cake, this company should be on the Nyse, Nasdaq market.
4 years and 6 months of existence and still there.